No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs558620463 |
chr15:99862628-99862629 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs576973976 |
chr15:99862647-99862648 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs541130675 |
chr15:99862662-99862663 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs563276495 |
chr15:99862668-99862669 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs182351553 |
chr15:99862673-99862674 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs111878414 |
chr15:99862675-99862676 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs112557335 |
chr15:99862703-99862704 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs561269927 |
chr15:99862710-99862711 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs530575549 |
chr15:99862712-99862713 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs185042862 |
chr15:99862726-99862727 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs542249540 |
chr15:99862881-99862882 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs192067834 |
chr15:99862888-99862889 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs183965330 |
chr15:99862897-99862898 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs532201086 |
chr15:99862919-99862920 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs547481476 |
chr15:99862943-99862944 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs188668199 |
chr15:99863012-99863013 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs530342464 |
chr15:99863079-99863080 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs191945204 |
chr15:99863094-99863095 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs140367080 |
chr15:99863108-99863109 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs537046872 |
chr15:99863156-99863157 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs370448221 |
chr15:99863157-99863158 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs552108460 |
chr15:99863219-99863220 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs570522572 |
chr15:99863225-99863226 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs531641479 |
chr15:99863231-99863232 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs534774345 |
chr15:99863322-99863323 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs77556127 |
chr15:99863376-99863377 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs547600367 |
chr15:99863386-99863387 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs572127607 |
chr15:99863460-99863461 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs536485796 |
chr15:99863467-99863468 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs554563605 |
chr15:99863502-99863503 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs183258600 |
chr15:99863512-99863513 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs543746971 |
chr15:99863560-99863561 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs564946363 |
chr15:99863564-99863565 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs187187609 |
chr15:99863609-99863610 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs8024982 |
chr15:99863613-99863614 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
36 |
rs35362785 |
chr15:99863626-99863627 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs551702157 |
chr15:99863645-99863646 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs570002524 |
chr15:99863664-99863665 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs367831811 |
chr15:99863668-99863669 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs537484213 |
chr15:99863716-99863717 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs114940467 |
chr15:99863825-99863826 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs191780352 |
chr15:99863844-99863845 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs563546009 |
chr15:99863849-99863850 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs183952724 |
chr15:99863875-99863876 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs186739198 |
chr15:99863890-99863891 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs570486385 |
chr15:99863923-99863924 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs549088100 |
chr15:99863978-99863979 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs111257251 |
chr15:99864057-99864058 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs547171355 |
chr15:99864059-99864060 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs79552925 |
chr15:99864060-99864061 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|